Question
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industryJohnson and Johnson (J&J) and Pfizer, Inc. ($
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industryJohnson and Johnson (J&J) and Pfizer, Inc. ($ in millions, except per share amounts).
Balance Sheets ($ in millions, except per share data) | |||||||
J&J | Pfizer | ||||||
Assets: | |||||||
Cash | $ | 8,195 | $ | 3,980 | |||
Short-term investments | 4,668 | 10,924 | |||||
Accounts receivable (net) | 7,154 | 9,355 | |||||
Inventories | 4,112 | 6,751 | |||||
Other current assets | 3,930 | 3,795 | |||||
Current assets | 28,059 | 34,805 | |||||
Property, plant, and equipment (net) | 11,270 | 19,711 | |||||
Intangibles and other assets | 16,446 | 69,771 | |||||
Total assets | $ | 55,775 | $ | 124,287 | |||
Liabilities and Shareholders' Equity: | |||||||
Accounts payable | $ | 5,506 | $ | 3,141 | |||
Short-term notes | 2,063 | 9,742 | |||||
Other current liabilities | 7,843 | 12,738 | |||||
Current liabilities | 15,412 | 25,621 | |||||
Long-term debt | 3,455 | 6,255 | |||||
Other long-term liabilities | 5,483 | 22,478 | |||||
Total liabilities | 24,350 | 54,354 | |||||
Capital stock (par and additional paid-in capital) | 3,720 | 67,650 | |||||
Retained earnings | 35,023 | 33,802 | |||||
Accumulated other comprehensive income (loss) | (670 | ) | 215 | ||||
Less: Treasury stock and other equity adjustments | (6,648 | ) | (31,734 | ) | |||
Total shareholders' equity | 31,425 | 69,933 | |||||
Total liabilities and shareholders' equity | $ | 55,775 | $ | 124,287 | |||
Income Statements | |||||||
Net sales | $ | 44,002 | $ | 47,328 | |||
Cost of goods sold | 12,680 | 10,336 | |||||
Gross profit | 31,322 | 36,992 | |||||
Operating expenses | 20,251 | 28,974 | |||||
Other (income) expensenet | (445 | ) | 3,670 | ||||
Income before taxes | 11,516 | 4,348 | |||||
Tax expense | 3,455 | 1,304 | |||||
Net income | $ | 8,061 | $ | 3,044 | * | ||
Basic net income per share | $ | 2.62 | $ | 0.42 | |||
* This is before income from discontinued operations. Evaluate and compare the two companies by responding to the following questions. Note: Because two-year comparative statements are not provided, you should use year-end balances in place of average balances as appropriate. Required: 1. For both companies, compute the ratios below. 2. Evaluate and compare the two companies.
|
|
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started